iPlan RT is a radiation treatment planning system that is intended for use in stereotactic, confo...

FDA Device Recall #Z-0957-2015 — Class II — November 19, 2014

Recall Summary

Recall Number Z-0957-2015
Classification Class II — Moderate risk
Date Initiated November 19, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Brainlab AG
Location Feldkirchen
Product Type Devices
Quantity 1412 systems total

Product Description

iPlan RT is a radiation treatment planning system that is intended for use in stereotactic, conformal, computer planned, Linac based radiation treatment of cranial, head and neck, and extracranial lesions.

Reason for Recall

iPlan RT Radiation Treatment Planning Software: Potentially incorrect patient positioning when using multiple localized CT image data sets.

Distribution Pattern

Worldwide Distribution - USA including Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, Wyoming and Internationally to Algeria, Angola, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Dominican Republic, Ecuador, Finland, France, Germany, Greece, Honduras, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Kazakhstan, Latvia, Lebanon, Lithuania, Malaysia, Mexico, Netherlands, Norway, Oman, Panama, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, Uruguay, and Venezuela.

Lot / Code Information

Software Versions: 1) 21213 IPLAN RT DOSE 3.0 PLATFORM; 2) 21213A IPLAN RT DOSE 3.0.1 PLATFORM; 3) 21213B IPLAN RT DOSE 3.0.2 PLATFORM; 4) 21213D IPLAN RT DOSE 4.1.0 PLATFORM; 5) 21213E IPLAN RT DOSE 4.1.1 PLATFORM; 6) 21213F IPLAN RT DOSE 4.1.2 PLATFORM; 7) 21213G IPLAN RT DOSE 4.1.3 PLATFORM; 8) 21213H IPLAN RT DOSE 4.1.4 PLATFORM; 9) 21381 IPLAN RT DOSE 4.5.0 PLATFORM; 10) 21381A IPLAN RT DOSE 4.5.1 PLATFORM; 11) 21381B IPLAN RT DOSE 4.5.2 PLATFORM; 12) 21381C IPLAN RT DOSE 4.5.3 PLATFORM; 13) 21385 UPGRADE IPLAN RT DOSE 4.X TO 4.5.0; 14) 21385A UPGRADE IPLAN RT DOSE 4.X TO 4.5.1; 15) 21385B UPGRADE IPLAN RT DOSE 4.X TO 4.5.2; 16) 21385C UPGRADE IPLAN RT DOSE 4.X TO 4.5.3; 17) 21387 iPLAN RT DOSE PLATFORM 4.1 (21213); 18) 21387A iPLAN RT DOSE PLATFORM 4.1.2 (21213); 19) 21387B iPLAN RT DOSE PLATFORM 4.5.1 (21381); 20) 21387C iPLAN RT DOSE PLATFORM 4.5.2 (21381); 21) 21387D IPLAN RT DOSE PLATFORM 4.5.3(21381) V; 22) 70213 UPGRADE BRAINSCAN 5.X TO iPLAN RT DOSE 3; 23) 70213A UPGRADE BRAINSCAN 5.X TO iPLAN RT DOSE 3; 24) 70213B UPG BRAINSCAN 5.X TO iPLAN RT DOSE 3.0; 25) 70213C UPG BRAINSCAN 5.X TO iPLAN RT DOSE4.1.0; 26) 70213D UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.1.1; 27) 70213E UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.1.2; 28) 70213F UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.5.1; 29) 70214 UPGRADE BRAINSCAN 3.X/ 4.X TO IPLAN RT D; 30) 70214A UPGRADE BRAINSCAN 3.X/ 4.X TO IPLAN RT D; 31) 70214B UPG BRAINSC 3.X/4.X TO IPLAN RT DOSE 3.0; 32) 70214C UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.0; 33) 70214D UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.1; 34) 70214E UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.2; 35) 70214F UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.5.1; 36) 70226 UPGRADE IPLAN RT DOSE 3.0 TO 3.0.1; 37) 70226A UPGRADE IPLAN RT DOSE TO 3.0.2; 38) 70228 UPGRADE IPLAN RT DOSE 3.X TO 4.0; 39) 70228A UPG IPLAN RT DOSE 3.X TO 4.1.0; 40) 70228B UPG IPLAN RT DOSE 3.X TO 4.1.1; 41) 70228C UPG IPLAN RT DOSE 3.X TO 4.1.2; 42) 70228D UPG IPLAN RT DOSE 3.X TO 4.5.1; 43) 70228E UPG IPLAN RT DOSE 3.X TO 4.5.2; 44) 70228F UPG IPLAN RT DOSE 3.X TO 4.5.3; 45) 70235 UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5; 46) 70235A UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5.2; 47) 70235B UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5.3; 48) 70237 UPD IPLAN RT DOSE 4.x TO 4.5 (0TRANSFER); 49) 70237A UPD IPLAN RT DOSE 4.x TO 4.5.2 (O TRANS); 50) 70237B UPD IPLAN RT DOSE 4.x TO 4.5.3(O TRANS); 51) 70263 UPD IPLAN RT DOSE 4.1.x to 4.1.3.(0TRA); 52) 70440 UPD iPLAN RT DOSE 4.1.0 TO 4.1.1; 53) 70440A UPD iPLAN RT DOSE 4.1 TO 4.1.2; 54) 20146 2ND LICENCE SW - FOR ONE ADDITIONAL WS; 55) 20147 RT SRS 2ND LICENCE SW FOR ONE ADD SITE; 56) 20148 NOVALIS TX 2ND LICENCE SW ONE ADD SITE

Other Recalls from Brainlab AG

Recall # Classification Product Date
Z-1392-2025 Class II Origin Data Management software versions 3.1.0,... Feb 10, 2025
Z-1292-2023 Class II Cirq Arm System 2.0 Mar 2, 2023
Z-1259-2023 Class II Brainlab ExacTrac Dynamic software, Medical Cha... Feb 14, 2023
Z-0733-2022 Class II ExacTrac Dynamic software model numbers: 209... Feb 25, 2022
Z-1846-2021 Class II ExacTrac Dynamic software, Model 20910-01B ETD ... May 14, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.